| Primary |
| Hyperinsulinism |
19.7% |
| Testicular Germ Cell Tumour Mixed Stage Iii |
9.1% |
| Chylothorax |
6.1% |
| Gastrointestinal Haemorrhage |
6.1% |
| Thymic Cancer Metastatic |
6.1% |
| Urinary Tract Infection |
6.1% |
| Diarrhoea |
4.5% |
| Grand Mal Convulsion |
4.5% |
| Hyperinsulinaemia |
4.5% |
| Short-bowel Syndrome |
4.5% |
| Acromegaly |
3.0% |
| Carcinoid Tumour |
3.0% |
| Gigantism |
3.0% |
| Haemorrhage |
3.0% |
| Hypertension |
3.0% |
| Insulinoma |
3.0% |
| Neuroendocrine Carcinoma Metastatic |
3.0% |
| Pancreatic Neuroendocrine Tumour |
3.0% |
| Sedative Therapy |
3.0% |
| Abdominal Pain Upper |
1.5% |
|
| Growth Retardation |
9.4% |
| Renal Failure Acute |
9.4% |
| Cardiac Arrest |
6.3% |
| Death |
6.3% |
| Gastrointestinal Haemorrhage |
6.3% |
| Lymphoma |
6.3% |
| Pneumothorax |
6.3% |
| Pulmonary Embolism |
6.3% |
| Supraventricular Tachycardia |
6.3% |
| Upper Respiratory Tract Infection |
6.3% |
| Anorectal Infection |
3.1% |
| Back Pain |
3.1% |
| Diabetic Retinopathy |
3.1% |
| Diarrhoea |
3.1% |
| Drug Ineffective |
3.1% |
| Drug-induced Liver Injury |
3.1% |
| Dyspnoea |
3.1% |
| Flushing |
3.1% |
| Gait Spastic |
3.1% |
| Haematochezia |
3.1% |
|
| Secondary |
| Hyperinsulinism |
24.7% |
| Prostate Cancer Metastatic |
8.1% |
| Grand Mal Convulsion |
7.5% |
| Product Used For Unknown Indication |
6.5% |
| Urinary Tract Infection |
6.5% |
| Pancreatic Neuroendocrine Tumour |
5.9% |
| Pancreatic Carcinoma Metastatic |
5.4% |
| Carcinoid Tumour |
4.8% |
| Acromegaly |
4.3% |
| Gastrointestinal Angiodysplasia Haemorrhagic |
3.2% |
| Insulinoma |
3.2% |
| Pancreatic Neuroendocrine Tumour Metastatic |
3.2% |
| Colitis Microscopic |
2.7% |
| Pancreatic Carcinoma |
2.7% |
| Diabetes Mellitus |
2.2% |
| Neuroendocrine Carcinoma |
2.2% |
| Neuroendocrine Tumour |
2.2% |
| Thymic Cancer Metastatic |
2.2% |
| Chylothorax |
1.6% |
| Diabetic Ketoacidosis |
1.1% |
|
| Growth Retardation |
26.4% |
| Pneumothorax |
5.7% |
| Pyogenic Granuloma |
5.7% |
| Small Intestinal Obstruction |
5.7% |
| Upper Respiratory Tract Infection |
5.7% |
| Weight Decreased |
5.7% |
| Weight Increased |
5.7% |
| Angiopathy |
3.8% |
| Hepatic Lesion |
3.8% |
| Hydrocephalus |
3.8% |
| Hypoglycaemia |
3.8% |
| Hypopituitarism |
3.8% |
| Oedema Peripheral |
3.8% |
| Red Blood Cell Count Decreased |
3.8% |
| Urinary Tract Infection |
3.8% |
| Anorectal Infection |
1.9% |
| Colitis Microscopic |
1.9% |
| Death |
1.9% |
| Drug Effect Incomplete |
1.9% |
| Drug-induced Liver Injury |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.6% |
| Hypertension |
12.4% |
| Drug Use For Unknown Indication |
9.0% |
| Acromegaly |
5.5% |
| Prophylaxis |
4.7% |
| Colorectal Cancer Metastatic |
3.7% |
| Non-hodgkin's Lymphoma |
3.4% |
| Supplementation Therapy |
3.4% |
| Lipids Abnormal |
3.2% |
| Pain |
2.9% |
| Type 2 Diabetes Mellitus |
2.6% |
| Acute Lymphocytic Leukaemia |
2.4% |
| Prophylaxis Of Nausea And Vomiting |
2.4% |
| Microangiopathy |
2.1% |
| Ovarian Cancer |
2.1% |
| Vitamin D Deficiency |
2.1% |
| Blood Thyroid Stimulating Hormone Decreased |
1.8% |
| Colon Cancer |
1.8% |
| Hypothyroidism |
1.8% |
| Prophylaxis Against Graft Versus Host Disease |
1.8% |
|
| Death |
15.9% |
| Vomiting |
11.6% |
| Influenza Like Illness |
5.8% |
| Pancreatitis Acute |
5.8% |
| Rhabdomyolysis |
5.8% |
| Weight Decreased |
5.8% |
| Gastroenteritis |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Pancreatitis |
4.3% |
| Renal Failure Acute |
4.3% |
| Stevens-johnson Syndrome |
4.3% |
| Venoocclusive Disease |
4.3% |
| Cardiac Aneurysm |
2.9% |
| Diarrhoea |
2.9% |
| Haematuria |
2.9% |
| Hepatic Enzyme Increased |
2.9% |
| No Therapeutic Response |
2.9% |
| Platelet Count Decreased |
2.9% |
| Pruritus |
2.9% |
| Pyrexia |
2.9% |
|
